Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
FDA Grants Orphan Drug Designation to Cevidoplenib for ITP 2024-03-21 20:00
HanAll Biopharma Reports Full-Year 2023 Financial Results and Provides Business Update 2024-03-21 19:00
Biosion to Present Three Posters at the 2024 AACR Meeting 2024-03-21 19:00
111, Inc. Announces Fourth Quarter and Fiscal Year 2023 Financial Results 2024-03-21 16:47
Mabwell Presented IDDC™ Platform Technology and ADC Drug Development Achievements at the 14th World ADC London 2024-03-21 14:11
Ubie Launches Checkup Platform for Patient Self-Monitoring, Medication Management and Improved Provider Communication 2024-03-20 22:00
Origin Agritech Announces Breakthrough in High-Yield Corn Production Through Gene Editing 2024-03-20 20:00
So-Young Reports Unaudited Fourth Quarter and Fiscal Year 2023 Financial Results 2024-03-20 17:30
China Jo-Jo Drugstores Regains Compliance with Nasdaq Minimum Bid Price Requirement 2024-03-20 04:05
SGO 2024 | The First Published Clinical Data of Nectin-4-Targeting ADC Developed by Mabwell in Cervical Cancer Demonstrates Its Outstanding Therapeutic Potential 2024-03-19 22:00
Datasea Enters into Manufacturing Agreement to Accelerate Production and Deployment of its Hi-Tech Intelligent Acoustic Products 2024-03-19 22:00
Breakthrough in Treatment of Cervical High-Grade Squamous Intraepithelial Lesion: Release of Positive Results from Multicenter Phase III Global Clinical Study 2024-03-19 10:24
Waterdrop Launches Groundbreaking X Series Reverse Osmosis System, Redefining Standards for Clean, Healthy, and Sustainable Drinking Water 2024-03-19 10:07
Sanyou Bio and BioGeometry join forces to create a next-generation Antibody Drug Discovery Platform driven by AIGC 2024-03-19 08:00
Lunit Expands Presence in Europe: to Deliver AI-powered Cancer Screening Solution to France and Portugal 2024-03-18 21:00
WuXi AppTec Revenue Surpassed RMB40 Billion in 2023, and Adjusted Non-IFRS Net Profit Exceeded RMB10 Billion for the First Time 2024-03-18 20:32
Aquedeon Medical Announces First Patient Enrolled in the IDE Study of Duett(TM) Vascular Graft System 2024-03-18 20:00
Positive results from Phase II clinical trial (CGZ203 study) of Chiglitazar monotherapy for non-alcoholic steatohepatitis 2024-03-18 19:25
KeChow Pharma Announces NMPA Approval of Tunlametinib (HL-085) as the First Targeted Therapy for Patients with NRAS Mutated Advanced Melanoma and Previously Treated with PD-1/PD-L1 2024-03-18 18:02
Mediwave Earns Global Recognition at GLOMO Awards 2024 for Emergency Response HealthTech 2024-03-18 08:00
1 18 19 20 21 22 788